Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Rituximab-temozolomide-radiation combo shows promise in recurrent primary CNS lymphoma
Use of rituximab, temozolomide, and radiation appears safe and effective as salvage therapy for patients with recurrent or refractory primary central nervous system (CNS) lymphoma, according to a study in the Philippines, the results of which were presented at the recent AAN 2023.
Rituximab-temozolomide-radiation combo shows promise in recurrent primary CNS lymphoma
15 May 2023Toripalimab plus bevacizumab, SoC demonstrates promising efficacy for cervical cancer
Preliminary results of a single-arm, open-label, phase II trial demonstrated the efficacy of a combination regimen comprising toripalimab, bevacizumab, and platinum-based chemotherapy for women with refractory, recurrent, or metastatic cervical cancer.
Toripalimab plus bevacizumab, SoC demonstrates promising efficacy for cervical cancer
15 May 2023Can antipsychotic monotherapy prevent hospitalizations in schizophrenia?
A recent study has shown that antipsychotic monotherapy does not reduce the risk of hospitalization for severe physical health problems when compared with polypharmacy in patients with schizophrenia.
Can antipsychotic monotherapy prevent hospitalizations in schizophrenia?
10 May 2023Influenza vaccine wards off cardiovascular events, death in CAD patients
A meta-analysis of randomized trials has revealed that influenza vaccination is effective at preventing all-cause mortality, cardiovascular mortality, major acute cardiovascular events, and acute coronary syndrome (ACS) among patients with coronary artery disease (CAD), particularly in those with ACS.